Candel Therapeutics, Inc. Share Price
NASDAQ: CADL | Small CapCandel Therapeutics, Inc. Stock Performance
Open $12.43 | Prev. Close $12.01 | Circuit Range N/A |
Day Range $12.34 - $13.81 | Year Range $4.36 - $13.81 | Volume 1,22,253 |
Average Traded $13.21 |
Candel Therapeutics, Inc. Share Price Today
As of 20 August 2026, Candel Therapeutics, Inc.'s share price is $13.49. The stock opened at $12.43, compared to its previous close of $12.01. During today's trading session, Candel Therapeutics, Inc.'s share price traded between $12.34 and $13.81, with an average price of $13.07. Over the past 52 weeks, the stock has recorded a high of $13.81 and a low of $4.36. In terms of performance, Candel Therapeutics, Inc.'s share price has risen by 157.44% over the last six months and is up 132.99% on a year-on-year basis.
Candel Therapeutics, Inc. Share Price Chart
Candel Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $714.41M | PE Ratio (TTM) -18.74 | Dividend Yield N/A |
EPS (TTM) $-0.72 | Revenue (TTM) N/A | Return On Equity (TTM) -73.54% |
Profit Margin N/A | Debt to Equity 0.17 | Quarterly Earnings Growth YoY -5.85% |
Candel Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Candel Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Candel Therapeutics, Inc.
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase III clinical trials for the treatment of prostate cancer; Phase II clinical trials for the treatment of pancreatic cancer; and Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the?enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.
Candel Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $9.66 | $12.05 | +20.50% |
Jul 2026 | $10.59 | $10.00 | -2.91% |
Jun 2026 | $8.34 | $10.30 | +24.17% |
May 2026 | $6.22 | $8.29 | +34.44% |
Apr 2026 | $4.93 | $6.17 | +25.66% |
Mar 2026 | $5.10 | $4.91 | -6.30% |
Feb 2026 | $5.80 | $5.24 | -10.12% |
Jan 2026 | $5.59 | $5.83 | +3.00% |
Dec 2025 | $4.58 | $5.66 | +18.66% |
Nov 2025 | $5.34 | $4.77 | -11.34% |
Oct 2025 | $5.06 | $5.38 | +5.49% |
Sep 2025 | $5.82 | $5.10 | -11.92% |
CADL Share Price FAQs
What is Candel Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Candel Therapeutics, Inc. stock?
What is CADL's market capitalisation today?
What is CADL's net income for the last quarter?
What is the 5 year returns of CADL?
What is the high & low stock price of CADL today?
Can I buy CADL shares in India?